You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Miscellaneous solid tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

Completed
  • Ependymoma
  • +9 more
  • Nivolumab
  • NKTR-214
  • Little Rock, Arkansas
  • +17 more
Dec 8, 2022

Advanced Solid Tumor Trial in Bordeaux (MEDI5752)

Not yet recruiting
  • Advanced Solid Tumor
  • Bordeaux, France
    Institut Bergonie
May 24, 2023

Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors Trial (INCA33890)

Not yet recruiting
  • Solid Tumors
  • +2 more
  • (no location specified)
Apr 26, 2023

Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Nov 9, 2023

Solid Tumors Trial (GS-9911, Zimberelimab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Oct 9, 2023

NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT

Recruiting
  • Advanced Solid Tumors or Lymphomas
  • Changsha, Hunan, China
    Hunan Provincal Tumor Hospital
Oct 5, 2023

HER2-expressing Advanced Solid Tumors Trial (SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor

Not yet recruiting
  • HER2-expressing Advanced Solid Tumors
  • SHR-A1811 combined with Pyrotinib.
  • SHR-A1811 combined with other antitumor therapies
  • (no location specified)
Aug 28, 2023

Advanced Solid Tumors Trial (QL1706H)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Sep 18, 2023

Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

Not yet recruiting
  • Advanced Solid Tumors With Neuroendocrine Differentiation
  • (no location specified)
Nov 27, 2023

Advanced Solid Cancer Trial (ORB-011)

Not yet recruiting
  • Advanced Solid Cancer
  • (no location specified)
Jul 14, 2023

Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

Not yet recruiting
  • Advanced Solid Tumors
  • B-cell Non-Hodgkin Lymphomas
  • (no location specified)
Aug 31, 2023

Solid Tumors Trial (IBR854 Cell Injection)

Not yet recruiting
  • Solid Tumors
  • IBR854 Cell Injection
  • (no location specified)
Aug 14, 2023

Advanced Solid Tumors Trial in Hangzhou (ZGGS15)

Not yet recruiting
  • Advanced Solid Tumors
  • ZGGS15
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 17, 2023

Advanced Solid Tumor Trial (7MW3711 for injection)

Not yet recruiting
  • Advanced Solid Tumor
  • 7MW3711 for injection
  • (no location specified)
Aug 18, 2023

Tumor Vaccines for Solid Tumors

Recruiting
  • Glioma
  • Solid Tumor
  • tumor vaccine
  • +3 more
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Oct 22, 2023

Solid Tumor Trial (DR30206)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Nov 14, 2023

Solid Tumor Trial (TL118 Capsule)

Not yet recruiting
  • Solid Tumor
  • TL118 Capsule
  • (no location specified)
Aug 18, 2023

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023

Advanced Solid Tumors Trial in Wuhan (HV-101)

Recruiting
  • Advanced Solid Tumors
  • HV-101
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
May 11, 2023

Advanced Solid Tumors Trial (SKB410 for injection)

Not yet recruiting
  • Advanced Solid Tumors
  • SKB410 for injection
  • (no location specified)
Jun 13, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (DS-3939a)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
May 12, 2023

Advanced Solid Tumor Trial in Guangzhou (YL-17231)

Recruiting
  • Advanced Solid Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 5, 2023

GT316,Solid Tumors,Adult Trial in Zhengzhou (GT316)

Recruiting
  • GT316,Solid Tumors,Adult
  • GT316
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Oct 16, 2023

NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

Not yet recruiting
  • NSCLC
  • +3 more
  • YL202 should be intravenously infused
  • Chang chun, Jilin, China
    Jilin Provincial Cancer Hospital
Oct 25, 2023

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023